Exhibit 99.6
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of BioDelivery Sciences International, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: May 21, 2018 | BROADFIN CAPITAL, LLC | |
By: | /s/ Kevin Kotler | |
Name: | Kevin Kotler | |
Title: | Managing Member |
BROADFIN HEALTHCARE MASTER FUND, LTD. | ||
By: | /s/ Kevin Kotler | |
Name: | Kevin Kotler | |
Title: | Director |
/s/ Kevin Kotler | |
Kevin Kotler Individually and as attorney-in-fact for Todd C. Davis, Peter S. Greenleaf and Stephen T. Wills |